{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:49:05Z","timestamp":1791571745320,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.clml.2018.01.006","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T10:57:18Z","timestamp":1517482638000},"page":"210-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Assessing the Effect of Adherence on Patient-reported Outcomes and Out of Pocket Costs Among Patients With Multiple Myeloma"],"prefix":"10.1016","volume":"18","author":[{"given":"Shaloo","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safiya","family":"Abouzaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Liebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejal","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Ung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron S.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2018.01.006_bib1","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(14)60493-1","article-title":"Multiple myeloma","volume":"385","author":"Rollig","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2018.01.006_bib2","author":"National Cancer Institute"},{"key":"10.1016\/j.clml.2018.01.006_bib3","unstructured":"American Cancer Society. Available at: multiple myeloma. http:\/\/www.cancer.org\/acs\/groups\/cid\/documents\/webcontent\/003121-pdf.pdf. Accessed October 17,\u00a02016."},{"key":"10.1016\/j.clml.2018.01.006_bib4","series-title":"Recent Results in Cancer Research","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-540-85772-3_2","article-title":"Epidemiology of multiple myeloma","author":"Becker","year":"2011"},{"key":"10.1016\/j.clml.2018.01.006_bib5","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1182\/blood-2014-07-552059","article-title":"Curing myeloma at last: defining criteria and providing the evidence","volume":"124","author":"Barlogie","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.01.006_bib6","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.01.006_bib7","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","article-title":"Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients","volume":"28","author":"Kumar","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2018.01.006_bib8","author":"National Comprehensive Cancer Network"},{"key":"10.1016\/j.clml.2018.01.006_bib9","author":"CancerMPact"},{"key":"10.1016\/j.clml.2018.01.006_bib10","first-page":"e12413","article-title":"Do patients on oral chemotherapy have sufficient knowledge for optimal adherence? A mixed methods study","volume":"26","author":"Arber","year":"2017","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.clml.2018.01.006_bib11","first-page":"397","article-title":"A\u00a0retrospective study of direct cost to patients associated with the use of oral oncology medications for the treatment of multiple myeloma","volume":"19","author":"Lee","year":"2016","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.clml.2018.01.006_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4274\/Tjh.2012.0192","article-title":"Quality of life and supportive care in multiple myeloma","volume":"30","author":"Comert","year":"2013","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.clml.2018.01.006_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1586\/17474086.2015.1021772","article-title":"Optimizing quality of life in multiple myeloma patients: current options, challenges, and recommendations","volume":"8","author":"Maes","year":"2015","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.clml.2018.01.006_bib14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpainsymman.2012.11.003","article-title":"Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life","volume":"46","author":"Boland","year":"2013","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.clml.2018.01.006_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0609.2012.01831.x","article-title":"Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry","volume":"89","author":"Mols","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2018.01.006_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1600-0609.2009.01303.x","article-title":"Health-related quality of life assessment in randomized controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations","volume":"83","author":"Kvam","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2018.01.006_bib17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/NCC.0b013e3182693522","article-title":"Personal financial effects of multiple myeloma and its treatment","volume":"36","author":"Goodwin","year":"2013","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.clml.2018.01.006_bib18","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1016\/S2352-3026(15)00151-9","article-title":"Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study","volume":"2","author":"Huntington","year":"2015","journal-title":"Lancet Hematol"},{"key":"10.1016\/j.clml.2018.01.006_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.clml.2018.01.006_bib20","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jpainsymman.2011.06.019","article-title":"Content development for the Functional Assessment of Cancer Therapy\u2013Multiple Myeloma (FACT-MM): use of qualitative and quantitative methods for scale construction","volume":"43","author":"Wagner","year":"2012","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.clml.2018.01.006_bib21","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2018.01.006_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Med Care"},{"key":"10.1016\/j.clml.2018.01.006_bib23","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1590\/S0102-311X2008001200030","article-title":"Prevalence of anti-hypertensive treatment adherence in patients with resistant hypertension and validation of three indirect methods for assessing treatment adherence [in Portuguese]","volume":"24","author":"Bloch","year":"2008","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.clml.2018.01.006_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work\u00a0productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.clml.2018.01.006_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2017.35.6_suppl.487","article-title":"Health-related quality of life (HRQoL), treatment satisfaction, and work productivity for patients (Pts) with advanced renal cell carcinoma (aRCC) in a chart review across six countries","volume":"35","author":"Hawkins","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2018.01.006_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.breast.2014.08.004","article-title":"Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: results from a substudy of the VIRGO observational cohort study","volume":"23","author":"Cleeland","year":"2014","journal-title":"Breast"},{"key":"10.1016\/j.clml.2018.01.006_bib27","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1182\/blood.V128.22.4256.4256","article-title":"Impact of myeloproliferative neoplasms on patients\u2019 employment status and work productivity in the United States: results from the living with MPN patient survey","volume":"128","author":"Yu","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.01.006_bib28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1182\/blood.V128.22.537.537","article-title":"Health-related quality of life of patients with newly diagnosed multiple myeloma receiving any or lenalidomide maintenance after autologous stem cell transplant in the Connect\u00ae MM Disease Registry","volume":"128","author":"Abonour","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.01.006_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1200\/JCO.2017.35.8_suppl.24","article-title":"Health utility scores (HUS) and health-related quality of life (HRQoL) in stage 4 lung cancer (S4LC) patients with brain metastases (BM)","volume":"35","author":"Tam","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2018.01.006_bib30","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1182\/blood.V124.21.1303.1303","article-title":"Quality of life burden among patients with myelodysplastic syndromes: analysis of survey data","volume":"124","author":"Kurtin","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.01.006_bib31","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/annonc\/mds539","article-title":"The FACT-G7: a rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and research","volume":"24","author":"Yanez","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2018.01.006_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/PROM.S10621","article-title":"Meta-analysis provides evidence-based interpretation guidelines for the clinical significance of mean differences for the FACT-G, a cancer-specific quality of life questionnaire","volume":"1","author":"King","year":"2010","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1016\/j.clml.2018.01.006_bib33","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ajh.23753","article-title":"Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents","volume":"89","author":"Al-Hamadani","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2018.01.006_bib34","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.bbmt.2013.08.002","article-title":"Trends in the utilization and outcomes of autologous transplantation as early therapy for multiple myeloma","volume":"19","author":"Costa","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2018.01.006_bib35","doi-asserted-by":"crossref","first-page":"djv139","DOI":"10.1093\/jnci\/djv139","article-title":"The real world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma","volume":"107","author":"Winn","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clml.2018.01.006_bib36","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood.V128.22.846.846","article-title":"Racial\/ethnic and socioeconomic disparities in the use of autologous hematopoietic stem cell transplant (ASCT) among Californians with multiple myeloma (MM)","volume":"128","author":"Rosenberg","year":"2016","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1016\/j.clml.2018.07.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000}}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265017314118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265017314118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:30:19Z","timestamp":1761870619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265017314118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2152265017314118"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2018.01.006","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the Effect of Adherence on Patient-reported Outcomes and Out of Pocket Costs Among Patients With Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2018.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}